Product Information

GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.1977 per ML under NDC 51672531609. Its NADAC has been published 185 times since May 10, 2023.

FDA first approved this application on Jul 5, 2022. Its Orange Book therapeutic-equivalence code is AA.

GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION

Glycopyrrolate Oral Solution
$0.1977per ML

Strength

1 mg/5mL

NDC

51672531609

Classification

Generic

Dosage Form

LIQUID

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

GLYCOPYRROLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA212467

FDA Approved

7/5/2022

TE Code

AA

On Market Since

7/5/2022

Pharmacological Classes

Anticholinergic
Cholinergic Antagonists
Cholinergic Muscarinic Antagonist
Cholinergic Muscarinic Antagonists

Price Statistics

The NADAC for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION has been published 185 times since May 10, 2023, and over the history we have for it it has declined 57.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1977 per ML
All-time high$0.5285 (Jul 12, 2023)
All-time low$0.1689 (May 20, 2026)
52-week high$0.2491
52-week low$0.1689
Median price$0.3340
Average price$0.3343
Largest weekly change+40.9% (Nov 20, 2024)
Weeks tracked185
Tracking sinceMay 10, 2023

Price History

1W

+2.6%

1M

-2.1%

3M

-2.5%

6M

+17.0%

1Y

-18.5%

3Y

-61.8%

5Y

N/A

All

-57.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Glycopyrrolate Oral Solution market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION?

The current National Average Drug Acquisition Cost (NADAC) for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.1977 per ML (NDC 51672531609), effective Nov 18, 2026.

How has the price of GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION changed over time?

Over the history we have for it, the NADAC for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION has declined 57.5%. It has been tracked across 185 weekly CMS publications since May 10, 2023.

What are the highest and lowest recorded NADAC prices for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION?

Since May 10, 2023, the NADAC for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION has ranged from a low of $0.1689 (May 20, 2026) to a high of $0.5285 (Jul 12, 2023), with a median of $0.3340 per ML.

Are there cheaper alternatives to GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION?

No other NADAC-published product currently shares the active ingredient and strength of GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION?

GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION (NDC 51672531609) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.